Click for best price
Pharmaceutical CDMO Services Market Size, Share 2022
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
This report contains market size and forecasts of Pharmaceutical CDMO Services in Global, including the following market information:
Global Pharmaceutical CDMO Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical CDMO Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Substance Development and Manufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, Catalent, Inc., Amatsigroup, WuXi AppTec Group, Strides Pharma Science Limited and Piramal Pharma Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutical CDMO Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical CDMO Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Type, 2021 (%)
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Global Pharmaceutical CDMO Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, by Application, 2021 (%)
Innovative Medicine
Patented Drug
Patent Expired Drug
Global Pharmaceutical CDMO Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical CDMO Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical CDMO Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical CDMO Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
| Report Attributes |
Report Details |
| Report Title |
Pharmaceutical CDMO Services Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical CDMO Services Overall Market Size
2.1 Global Pharmaceutical CDMO Services Market Size: 2021 VS 2028
2.2 Global Pharmaceutical CDMO Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceutical CDMO Services Players in Global Market
3.2 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue
3.3 Global Pharmaceutical CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical CDMO Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutical CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceutical CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pharmaceutical CDMO Services Market Size Markets, 2021 & 2028
4.1.2 Drug Substance Development and Manufacturing
4.1.3 Specialized Services
4.1.4 Lab-based Services
4.2 By Type - Global Pharmaceutical CDMO Services Revenue & Forecasts
4.2.1 By Type - Global Pharmaceutical CDMO Services Revenue, 2017-2022
4.2.2 By Type - Global Pharmaceutical CDMO Services Revenue, 2023-2028
4.2.3 By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
5.1.2 Innovative Medicine
5.1.3 Patented Drug
5.1.4 Patent Expired Drug
5.2 By Application - Global Pharmaceutical CDMO Services Revenue & Forecasts
5.2.1 By Application - Global Pharmaceutical CDMO Services Revenue, 2017-2022
5.2.2 By Application - Global Pharmaceutical CDMO Services Revenue, 2023-2028
5.2.3 By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pharmaceutical CDMO Services Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical CDMO Services Revenue & Forecasts
6.2.1 By Region - Global Pharmaceutical CDMO Services Revenue, 2017-2022
6.2.2 By Region - Global Pharmaceutical CDMO Services Revenue, 2023-2028
6.2.3 By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pharmaceutical CDMO Services Revenue, 2017-2028
6.3.2 US Pharmaceutical CDMO Services Market Size, 2017-2028
6.3.3 Canada Pharmaceutical CDMO Services Market Size, 2017-2028
6.3.4 Mexico Pharmaceutical CDMO Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pharmaceutical CDMO Services Revenue, 2017-2028
6.4.2 Germany Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.3 France Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.4 U.K. Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.5 Italy Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.6 Russia Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.7 Nordic Countries Pharmaceutical CDMO Services Market Size, 2017-2028
6.4.8 Benelux Pharmaceutical CDMO Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pharmaceutical CDMO Services Revenue, 2017-2028
6.5.2 China Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.3 Japan Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.4 South Korea Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.5 Southeast Asia Pharmaceutical CDMO Services Market Size, 2017-2028
6.5.6 India Pharmaceutical CDMO Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pharmaceutical CDMO Services Revenue, 2017-2028
6.6.2 Brazil Pharmaceutical CDMO Services Market Size, 2017-2028
6.6.3 Argentina Pharmaceutical CDMO Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, 2017-2028
6.7.2 Turkey Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.3 Israel Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.4 Saudi Arabia Pharmaceutical CDMO Services Market Size, 2017-2028
6.7.5 UAE Pharmaceutical CDMO Services Market Size, 2017-2028
7 Players Profiles
7.1 Recipharm AB
7.1.1 Recipharm AB Corporate Summary
7.1.2 Recipharm AB Business Overview
7.1.3 Recipharm AB Pharmaceutical CDMO Services Major Product Offerings
7.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.1.5 Recipharm AB Key News
7.2 AMRI Global
7.2.1 AMRI Global Corporate Summary
7.2.2 AMRI Global Business Overview
7.2.3 AMRI Global Pharmaceutical CDMO Services Major Product Offerings
7.2.4 AMRI Global Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.2.5 AMRI Global Key News
7.3 Patheon N.V.
7.3.1 Patheon N.V. Corporate Summary
7.3.2 Patheon N.V. Business Overview
7.3.3 Patheon N.V. Pharmaceutical CDMO Services Major Product Offerings
7.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.3.5 Patheon N.V. Key News
7.4 Aenova Group
7.4.1 Aenova Group Corporate Summary
7.4.2 Aenova Group Business Overview
7.4.3 Aenova Group Pharmaceutical CDMO Services Major Product Offerings
7.4.4 Aenova Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.4.5 Aenova Group Key News
7.5 Catalent, Inc.
7.5.1 Catalent, Inc. Corporate Summary
7.5.2 Catalent, Inc. Business Overview
7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Major Product Offerings
7.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.5.5 Catalent, Inc. Key News
7.6 Amatsigroup
7.6.1 Amatsigroup Corporate Summary
7.6.2 Amatsigroup Business Overview
7.6.3 Amatsigroup Pharmaceutical CDMO Services Major Product Offerings
7.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.6.5 Amatsigroup Key News
7.7 WuXi AppTec Group
7.7.1 WuXi AppTec Group Corporate Summary
7.7.2 WuXi AppTec Group Business Overview
7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Major Product Offerings
7.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.7.5 WuXi AppTec Group Key News
7.8 Strides Pharma Science Limited
7.8.1 Strides Pharma Science Limited Corporate Summary
7.8.2 Strides Pharma Science Limited Business Overview
7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Major Product Offerings
7.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.8.5 Strides Pharma Science Limited Key News
7.9 Piramal Pharma Solutions
7.9.1 Piramal Pharma Solutions Corporate Summary
7.9.2 Piramal Pharma Solutions Business Overview
7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Major Product Offerings
7.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.9.5 Piramal Pharma Solutions Key News
7.10 Siegfried Ltd
7.10.1 Siegfried Ltd Corporate Summary
7.10.2 Siegfried Ltd Business Overview
7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Major Product Offerings
7.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.10.5 Siegfried Ltd Key News
7.11 Fareva Group
7.11.1 Fareva Group Corporate Summary
7.11.2 Fareva Group Business Overview
7.11.3 Fareva Group Pharmaceutical CDMO Services Major Product Offerings
7.11.4 Fareva Group Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.11.5 Fareva Group Key News
7.12 FAMAR Health Care Services
7.12.1 FAMAR Health Care Services Corporate Summary
7.12.2 FAMAR Health Care Services Business Overview
7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Major Product Offerings
7.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue in Global Market (2017-2022)
7.12.5 FAMAR Health Care Services Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmaceutical CDMO Services Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical CDMO Services Market Drivers in Global Market
Table 3. Pharmaceutical CDMO Services Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical CDMO Services in Global Market
Table 5. Top Pharmaceutical CDMO Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutical CDMO Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutical CDMO Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutical CDMO Services Product Type
Table 9. List of Global Tier 1 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical CDMO Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutical CDMO Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pharmaceutical CDMO Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutical CDMO Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue, (US$, Mn), 2023-2028
Table 30. Recipharm AB Corporate Summary
Table 31. Recipharm AB Pharmaceutical CDMO Services Product Offerings
Table 32. Recipharm AB Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 33. AMRI Global Corporate Summary
Table 34. AMRI Global Pharmaceutical CDMO Services Product Offerings
Table 35. AMRI Global Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 36. Patheon N.V. Corporate Summary
Table 37. Patheon N.V. Pharmaceutical CDMO Services Product Offerings
Table 38. Patheon N.V. Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 39. Aenova Group Corporate Summary
Table 40. Aenova Group Pharmaceutical CDMO Services Product Offerings
Table 41. Aenova Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 42. Catalent, Inc. Corporate Summary
Table 43. Catalent, Inc. Pharmaceutical CDMO Services Product Offerings
Table 44. Catalent, Inc. Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 45. Amatsigroup Corporate Summary
Table 46. Amatsigroup Pharmaceutical CDMO Services Product Offerings
Table 47. Amatsigroup Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 48. WuXi AppTec Group Corporate Summary
Table 49. WuXi AppTec Group Pharmaceutical CDMO Services Product Offerings
Table 50. WuXi AppTec Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 51. Strides Pharma Science Limited Corporate Summary
Table 52. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offerings
Table 53. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 54. Piramal Pharma Solutions Corporate Summary
Table 55. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offerings
Table 56. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 57. Siegfried Ltd Corporate Summary
Table 58. Siegfried Ltd Pharmaceutical CDMO Services Product Offerings
Table 59. Siegfried Ltd Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 60. Fareva Group Corporate Summary
Table 61. Fareva Group Pharmaceutical CDMO Services Product Offerings
Table 62. Fareva Group Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
Table 63. FAMAR Health Care Services Corporate Summary
Table 64. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offerings
Table 65. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pharmaceutical CDMO Services Segment by Type in 2021
Figure 2. Pharmaceutical CDMO Services Segment by Application in 2021
Figure 3. Global Pharmaceutical CDMO Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical CDMO Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutical CDMO Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2021
Figure 8. By Type - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutical CDMO Services Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutical CDMO Services Revenue, (US$, Mn), 2017-2028
Figure 37. Recipharm AB Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AMRI Global Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Patheon N.V. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aenova Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Catalent, Inc. Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amatsigroup Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. WuXi AppTec Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Siegfried Ltd Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fareva Group Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
